Last 7 days
-8.2%
Last 30 days
-15.7%
Last 90 days
-16.1%
Trailing 12 Months
-54.6%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-09-07 | Jain Abhishek | sold (taxes) | -22,682 | 8.26 | -2,746 | chief financial officer |
2023-09-07 | Ronai Abraham | sold (taxes) | -12,100 | 8.26 | -1,465 | see remarks |
2023-09-06 | Jain Abhishek | sold (taxes) | -9,285 | 8.81 | -1,054 | chief financial officer |
2023-09-05 | Seeto Reginald | sold | -26,762 | 9.4935 | -2,819 | see remarks |
2023-08-14 | Seeto Reginald | sold | -5,122 | 8.8935 | -576 | see remarks |
2023-08-11 | Bickerstaff George | acquired | 99,064 | 5.09252 | 19,453 | - |
2023-08-07 | Seeto Reginald | sold (taxes) | -7,279 | 10.8 | -674 | see remarks |
2023-08-07 | Johnson Alexander L | sold (taxes) | -2,343 | 10.8 | -217 | chief business officer |
2023-08-02 | Seeto Reginald | sold | -31,987 | 11.3472 | -2,819 | see remarks |
2023-07-19 | Johnson Alexander L | sold (taxes) | -11,955 | 10.28 | -1,163 | chief business officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-20 | BARCLAYS PLC | added | 4.56 | -41,000 | 1,436,000 | -% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -2.17 | -54,405 | 548,497 | -% |
2023-08-21 | OSAIC HOLDINGS, INC. | reduced | -14.73 | -40,564 | 155,431 | -% |
2023-08-16 | Nuveen Asset Management, LLC | reduced | -50.7 | -1,375,930 | 1,165,070 | -% |
2023-08-15 | Belpointe Asset Management LLC | sold off | -100 | -3,519 | - | -% |
2023-08-15 | ALLIANCEBERNSTEIN L.P. | added | 12.73 | 27,871 | 604,605 | -% |
2023-08-15 | Bullseye Asset Management LLC | unchanged | - | -96,000 | 1,273,000 | 0.64% |
2023-08-15 | GOLDMAN SACHS GROUP INC | added | 17.37 | 612,612 | 7,305,630 | -% |
2023-08-15 | LAZARD ASSET MANAGEMENT LLC | sold off | -100 | -18,000 | - | -% |
2023-08-15 | WELLS FARGO & COMPANY/MN | reduced | -0.45 | -55,990 | 698,700 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Jul 07, 2023 | blackrock inc. | 10.1% | 5,439,512 | SC 13G/A | |
Mar 13, 2023 | gagnon securities llc | 4.7% | 2,522,063 | SC 13G | |
Feb 15, 2023 | arrowmark colorado holdings llc | 7.48% | 4,003,218 | SC 13G | |
Feb 14, 2023 | bellevue asset management (uk) ltd. | 5.9% | 3,168,448 | SC 13G | |
Feb 10, 2023 | ark investment management llc | 11.56% | 6,188,182 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.84% | 5,270,397 | SC 13G/A | |
Feb 08, 2023 | invesco ltd. | 0.2% | 88,421 | SC 13G/A | |
Feb 03, 2023 | blackrock inc. | 8.2% | 4,373,662 | SC 13G/A | |
Jan 10, 2023 | state street corp | 10.74% | 5,747,244 | SC 13G/A | |
Jan 10, 2023 | alger associates inc | 0.9% | 503,686 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 26, 2023 | 4 | Insider Trading | |
Sep 26, 2023 | 8-K | Current Report | |
Sep 25, 2023 | 8-K | Current Report | |
Sep 11, 2023 | 4 | Insider Trading | |
Sep 11, 2023 | 4 | Insider Trading | |
Sep 08, 2023 | 4 | Insider Trading | |
Sep 05, 2023 | 144 | Notice of Insider Sale Intent | |
Sep 05, 2023 | 4 | Insider Trading | |
Aug 14, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 14, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABBV | 272.0B | 56.0B | 4.92% | 10.10% | 31.31 | 4.85 | -2.31% | -31.27% |
VRTX | 90.7B | 9.5B | 0.47% | 27.06% | 26.94 | 9.54 | 13.83% | 5.33% |
REGN | 89.1B | 12.7B | 0.25% | 21.32% | 20.72 | 7.03 | -10.94% | -24.40% |
INCY | 13.2B | 3.5B | -7.17% | -10.43% | 36.13 | 3.77 | 5.81% | -61.22% |
MID-CAP | ||||||||
NTRA | 5.1B | 931.0M | -21.63% | 5.69% | -10.02 | 5.51 | 28.69% | 11.08% |
ARWR | 2.8B | 256.2M | -6.13% | -11.58% | -15.49 | 10.95 | 2.51% | -17.66% |
SMALL-CAP | ||||||||
VCYT | 1.6B | 328.6M | -11.21% | 30.44% | -56.44 | 4.99 | 22.46% | 40.27% |
CSTL | 430.3M | 167.5M | -13.77% | -32.41% | -4.84 | 2.57 | 52.01% | -99.69% |
CDNA | 397.5M | 309.3M | -15.69% | -54.62% | -4.73 | 1.29 | -1.76% | -21.01% |
ORGO | 340.1M | 457.3M | -2.63% | -17.52% | 33.85 | 0.74 | -0.61% | -85.93% |
CELC | 212.5M | - | -2.68% | 7.78% | -4.34 | - | - | -59.74% |
NVTA | 164.1M | 493.9M | -30.95% | -74.20% | -0.21 | 0.33 | -1.39% | 74.28% |
OPGN | 1.5M | 2.8M | 28.48% | -44.24% | -0.04 | 0.54 | -31.25% | -41.90% |
10.7%
-23.2%
-39.2%
100%
95%
57.7%
Y-axis is the maximum loss one would have experienced if CareDx was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | -3.2% | 309,306,000 | 319,639,000 | 321,793,000 | 318,629,000 | 314,859,000 | 308,413,000 | 296,397,000 | 275,821,000 | 253,601,000 | 221,214,000 | 192,194,000 | 169,371,000 | 149,813,000 | 139,466,000 | 127,068,000 | 114,756,000 | 102,129,000 | 88,498,000 | 76,569,000 | 65,563,000 | 56,570,000 |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | 98,186,000 | 91,352,000 | 81,613,000 | 71,508,000 | 61,488,000 | 52,162,000 | 43,582,000 | 45,826,000 | 42,464,000 |
Operating Expenses | -1.1% | 397,713,000 | 402,141,000 | 399,024,000 | 392,139,000 | 379,757,000 | 356,334,000 | 326,123,000 | 293,215,000 | 265,175,000 | 238,849,000 | 214,722,000 | 194,377,000 | 178,659,000 | 152,841,000 | 151,600,000 | 137,391,000 | 111,849,000 | 100,888,000 | 92,147,000 | 45,548,000 | 46,587,000 |
S&GA Expenses | -5.5% | 90,790,000 | 96,110,000 | 96,027,000 | 93,183,000 | 92,292,000 | 84,941,000 | 77,245,000 | 72,552,000 | 65,052,000 | 57,587,000 | 53,858,000 | 47,994,000 | 45,182,000 | 43,692,000 | 38,894,000 | 34,381,000 | 29,294,000 | 24,510,000 | 21,670,000 | 18,977,000 | 16,261,000 |
R&D Expenses | -2.6% | 90,466,000 | 92,865,000 | 90,388,000 | 88,864,000 | 85,997,000 | 82,401,000 | 76,525,000 | 67,804,000 | 60,839,000 | 54,932,000 | 48,941,000 | 44,562,000 | 40,609,000 | 35,110,000 | 30,711,000 | 25,547,000 | 20,894,000 | 16,760,000 | 14,514,000 | 13,760,000 | 12,851,000 |
EBITDA | 100.0% | - | -67,788,000 | -64,631,000 | - | -60,459,000 | -41,331,000 | -23,290,000 | - | - | -7,230,000 | -12,734,000 | -14,288,000 | -14,340,000 | -15,930,000 | -18,402,000 | -16,270,000 | -34,214,000 | -40,823,000 | - | - | - |
EBITDA Margin | 100.0% | - | -0.21 | -0.20 | - | -0.19 | -0.13 | -0.08 | - | - | -0.03 | -0.07 | -0.08 | -0.10 | -0.11 | -0.14 | -0.14 | -0.34 | -0.46 | - | - | - |
Interest Expenses | - | - | - | 8,000 | - | - | - | 1,000 | - | - | - | 10,000 | - | - | - | 22,000 | - | - | - | 1,774,000 | - | - |
Earnings Before Taxes | -4.1% | -83,474,000 | -80,199,000 | -76,234,000 | -75,130,000 | -70,517,000 | -50,798,000 | -32,088,000 | -18,722,000 | -9,716,000 | -14,577,000 | -19,750,000 | -21,045,000 | -20,754,000 | -21,933,000 | -23,947,000 | -23,060,000 | -40,558,000 | -46,934,000 | -48,215,000 | -76,622,000 | -70,827,000 |
EBT Margin | 100.0% | - | -0.25 | -0.24 | -0.24 | -0.22 | -0.16 | -0.11 | -0.07 | -0.04 | -0.07 | -0.10 | -0.12 | -0.14 | -0.16 | -0.19 | - | - | - | - | - | - |
Net Income | -4.0% | -83,970,000 | -80,714,000 | -76,613,000 | -74,435,000 | -69,393,000 | -49,623,000 | -30,662,000 | -18,026,000 | -8,947,000 | -13,578,000 | -18,714,000 | -19,976,000 | -18,971,000 | -20,260,000 | -21,968,000 | -20,946,000 | -39,103,000 | -45,318,000 | -46,756,000 | -74,672,000 | -68,970,000 |
Net Income Margin | 100.0% | - | -0.25 | -0.24 | -0.23 | -0.22 | -0.16 | -0.10 | -0.07 | -0.04 | -0.06 | -0.10 | -0.12 | -0.13 | -0.15 | -0.17 | - | - | - | - | - | - |
Free Cashflow | 100.0% | - | -3,100,000 | -25,239,000 | -28,258,000 | -20,797,000 | -17,413,333 | -29,575,333 | -26,560,333 | -21,219,333 | -5,432,000 | 24,537,667 | 16,273,667 | 15,441,000 | -2,798,333 | -4,699,000 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -2.5% | 515 | 528 | 543 | 545 | 541 | 547 | 567 | 563 | 557 | 541 | 369 | 354 | 345 | 157 | 152 | 145 | 143 | 128 | 131 | 91.00 | 80.00 |
Current Assets | -2.9% | 361 | 371 | 388 | 388 | 404 | 411 | 433 | 445 | 441 | 439 | 273 | 259 | 252 | 66.00 | 72.00 | 68.00 | 68.00 | 78.00 | 81.00 | 42.00 | 31.00 |
Cash Equivalents | 17.6% | 88.00 | 75.00 | 90.00 | 83.00 | 167 | 172 | 349 | 353 | 336 | 309 | 135 | 214 | 211 | 32.00 | 38.00 | 41.00 | 44.00 | 58.00 | 65.00 | 26.00 | 16.00 |
Inventory | 4.6% | 19.00 | 18.00 | 19.00 | 18.00 | 19.00 | 18.00 | 17.00 | 19.00 | 15.00 | 14.00 | 10.00 | 10.00 | 9.00 | 7.00 | 6.00 | 6.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Net PPE | - | - | - | - | - | - | - | - | 19.00 | 14.00 | 11.00 | 11.00 | 10.00 | 7.00 | 6.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 3.00 | 2.00 |
Goodwill | 0.1% | 40.00 | 40.00 | 38.00 | 38.00 | 37.00 | 37.00 | 37.00 | 26.00 | 26.00 | 26.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 23.00 | 12.00 | 12.00 | - | - |
Liabilities | 1.3% | 110 | 108 | 112 | 108 | 98.00 | 89.00 | 101 | 91.00 | 78.00 | 70.00 | 91.00 | 85.00 | 84.00 | 55.00 | 53.00 | 47.00 | 50.00 | 32.00 | 35.00 | 47.00 | 51.00 |
Current Liabilities | 3.7% | 74.00 | 72.00 | 76.00 | 70.00 | 78.00 | 67.00 | 77.00 | 70.00 | 56.00 | 46.00 | 69.00 | 62.00 | 57.00 | 28.00 | 35.00 | 31.00 | 29.00 | 16.00 | 20.00 | 16.00 | 14.00 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 13.00 | 13.00 |
Shareholder's Equity | -3.5% | 405 | 420 | 431 | 437 | 444 | 458 | 466 | 472 | 480 | 472 | 278 | 269 | 261 | 101 | 99.00 | 98.00 | 93.00 | 96.00 | 96.00 | 44.00 | 29.00 |
Retained Earnings | -5.2% | -509 | -484 | -460 | -441 | -424 | -402 | -383 | -367 | -355 | -353 | -352 | -349 | -346 | -339 | -333 | -329 | -327 | -319 | -311 | -308 | -288 |
Additional Paid-In Capital | 1.2% | 924 | 912 | 899 | 887 | 875 | 865 | 854 | 843 | 838 | 828 | 632 | 622 | 612 | 448 | 438 | 432 | 425 | 420 | 412 | 356 | 321 |
Shares Outstanding | 0.7% | 54.00 | 54.00 | 54.00 | 54.00 | 53.00 | 53.00 | 53.00 | 53.00 | 52.00 | 51.00 | 49.00 | 49.00 | 45.00 | 43.00 | 42.00 | 42.00 | 42.00 | 42.00 | 41.00 | 37.00 | 36.00 |
Minority Interest | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cashflow (Last 12 Months) | (In Thousands) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 109.0% | 278 | -3,100 | -25,239 | -28,258 | -20,797 | -7,132 | -19,294 | -16,279 | -11,454 | 2,856 | 33,431 | 25,167 | 20,565 | 43.00 | -2,769 | 312 | 106 | -5,356 | -4,007 | -8,155 | -10,774 |
Share Based Compensation | 0.2% | 49,780 | 49,673 | 46,553 | 43,925 | 43,363 | 40,168 | 36,081 | 32,560 | 28,670 | 25,689 | 23,401 | 22,831 | 22,048 | 20,623 | 22,417 | 19,070 | 14,966 | 12,485 | 7,138 | 5,506 | 4,075 |
Cashflow From Investing | 16.7% | -72,683 | -87,241 | -228,502 | -238,759 | -142,822 | -127,399 | 47,712 | -34,980 | -59,418 | -79,611 | -100,394 | -11,262 | -10,541 | -23,740 | -22,579 | -22,197 | -19,296 | -7,718 | -7,929 | -12,005 | -12,366 |
Cashflow From Financing | 6.6% | -6,107 | -6,538 | -4,535 | -2,997 | -5,099 | -2,721 | 185,642 | 190,440 | 194,797 | 353,112 | 163,149 | 159,267 | 158,789 | -179 | -132 | 37,098 | 46,550 | 51,898 | 50,268 | 30,876 | 20,786 |
Buy Backs | 9.7% | 1,514 | 1,380 | 642 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2,224 | - |
Condensed Consolidated Statements of Operations - USD ($) | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenue: | ||||
Total revenue | $ 70,301,000 | $ 80,634,000 | $ 147,563,000 | $ 160,050,000 |
Operating expenses: | ||||
Research and development | 20,233,000 | 22,632,000 | 44,590,000 | 44,512,000 |
Sales and marketing | 21,630,000 | 26,950,000 | 44,861,000 | 50,098,000 |
General and administrative | 29,327,000 | 25,232,000 | 57,359,000 | 51,791,000 |
Restructuring costs | 848,000 | 0 | 848,000 | 0 |
Total operating expenses | 97,925,000 | 102,353,000 | 199,511,000 | 200,822,000 |
Loss from operations | (27,624,000) | (21,719,000) | (51,948,000) | (40,772,000) |
Other income (expense): | ||||
Interest income, net | 2,871,000 | 478,000 | 5,537,000 | 667,000 |
Change in estimated fair value of common stock warrant liability | 3,000 | 48,000 | 10,000 | 75,000 |
Other expense, net | (271,000) | (553,000) | (2,245,000) | (1,376,000) |
Total other income (expense) | 2,603,000 | (27,000) | 3,302,000 | (634,000) |
Loss before income taxes | (25,021,000) | (21,746,000) | (48,646,000) | (41,406,000) |
Income tax benefit (expense) | 68,000 | 49,000 | (56,000) | 61,000 |
Net loss | $ (24,953,000) | $ (21,697,000) | $ (48,702,000) | $ (41,345,000) |
Net loss per share | ||||
Basic (in dollars per share) | $ (0.46) | $ (0.41) | $ (0.91) | $ (0.78) |
Diluted (in dollars per share) | $ (0.46) | $ (0.41) | $ (0.91) | $ (0.78) |
Weighted-average shares used to compute net loss per share: | ||||
Basic (in shares) | 53,846,260 | 53,249,545 | 53,745,299 | 53,133,149 |
Diluted (in shares) | 53,846,260 | 53,249,545 | 53,745,299 | 53,133,149 |
Testing services revenue | ||||
Revenue: | ||||
Total revenue | $ 53,414,000 | $ 67,135,000 | $ 115,198,000 | $ 133,579,000 |
Operating expenses: | ||||
Cost of testing services, product, digital, and other | 15,324,000 | 18,230,000 | 30,620,000 | 35,858,000 |
Product revenue | ||||
Revenue: | ||||
Total revenue | 7,876,000 | 6,714,000 | 14,737,000 | 13,502,000 |
Operating expenses: | ||||
Cost of testing services, product, digital, and other | 3,926,000 | 3,887,000 | 7,992,000 | 8,286,000 |
Patient and digital solutions revenue | ||||
Revenue: | ||||
Total revenue | 9,011,000 | 6,785,000 | 17,628,000 | 12,969,000 |
Operating expenses: | ||||
Cost of testing services, product, digital, and other | $ 6,637,000 | $ 5,422,000 | $ 13,241,000 | $ 10,277,000 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 87,786 | $ 89,921 |
Marketable securities | 194,887 | 203,168 |
Accounts receivable | 51,625 | 66,312 |
Inventory | 18,840 | 19,232 |
Prepaid and other current assets | 7,676 | 9,216 |
Total current assets | 360,814 | 387,849 |
Property and equipment, net | 36,084 | 35,529 |
Operating leases right-of-use assets | 32,118 | 34,689 |
Intangible assets, net | 43,529 | 43,051 |
Goodwill | 39,655 | 37,523 |
Restricted cash | 584 | 522 |
Other assets | 2,036 | 3,828 |
Total assets | 514,820 | 542,991 |
Current liabilities: | ||
Accounts payable | 9,880 | 9,942 |
Accrued compensation | 14,441 | 16,902 |
Accrued and other liabilities | 50,175 | 49,131 |
Total current liabilities | 74,496 | 75,975 |
Deferred tax liability | 51 | 0 |
Common stock warrant liability | 0 | 32 |
Deferred payments for intangible assets | 4,224 | 2,418 |
Operating lease liability, less current portion | 30,589 | 33,406 |
Other liabilities | 247 | 249 |
Total liabilities | 109,607 | 112,080 |
Commitments and contingencies (Note 9) | ||
Stockholders’ equity: | ||
Preferred stock: $0.001 par value; 10,000,000 shares authorized at June 30, 2023 and December 31, 2022; no shares issued and outstanding at June 30, 2023 and December 31, 2022 | 0 | 0 |
Common stock: $0.001 par value; 100,000,000 shares authorized at June 30, 2023 and December 31, 2022; 54,013,601 shares issued and outstanding at June 30, 2023; 53,583,301 shares issued and 53,533,250 shares outstanding at December 31, 2022 | 52 | 52 |
Additional paid-in capital | 923,514 | 898,806 |
Accumulated other comprehensive loss | (8,450) | (7,503) |
Accumulated deficit | (509,903) | (460,444) |
Total stockholders’ equity | 405,213 | 430,911 |
Total liabilities and stockholders’ equity | $ 514,820 | $ 542,991 |